Corrigendum re: "TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer" [Eur Urol 2016;70:709-13]

Affiliations

• ¹ Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
• ² Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
• ³ Medical Oncology Department, Hospital Plató, Barcelona, Spain.
• ⁴ Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
• ⁵ Department of Pathology, Hospital Clónic, Barcelona, Spain; University of Barcelona, Barcelona, Spain.
• ⁶ Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; University of Barcelona, Barcelona, Spain.
• ⁷ Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Electronic address: bmellado@clinic.ub.es.